Navigation Links
Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma
Date:1/14/2010

STOCKHOLM, January 14 /PRNewswire/ -- Karolinska Development AB (publ), and BioChromix AB announced today the formation of BioChromix Pharma AB, a new company working to develop a novel Alzheimer treatment with its unique knowledge of molecular chemistry. Karolinska Development will initially take 28 percent ownership in the new company.

"We are very excited about BioChromix Pharma as they have a novel approach that targets the cause of the disease. This is an important addition to our portfolio", says Conny Bogentoft, CEO of Karolinska Development.

"We have a clear goal - to bring our lead product candidates for Alzheimer's disease to the market. Being part of the Karolinska Development portfolio, will provided direct access to a broad network of key competencies and resources in the pharmaceutical industry which will be of great importance for us in order to succeed", says Peter Asberg, CEO of BioChromix Pharma AB.

About Karolinska Development

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

Using a unique, highly cost efficient business model, the management team guides the commercialization of world class life science innovations, helping to shape the next generation pharma industry. Since 2003, Karolinska Development has built a portfolio of some 40 companies; among the company's projects 12 compounds are undergoing clinical trials. The portfolio also includes a total of 19 potential first in class products. http://www.karolinskadevelopment.com'/>"/>

SOURCE Karolinska Development AB (publ), and BioChromix AB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation
2. Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial
3. Karolinska Development Closes Fully Subscribed New Share Issue
4. Karolinska Development Strengthens its Management Team With the Appointment of Dr Carl Harald Janson
5. Arena Pharmaceuticals Announces Merck Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis
6. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
7. AEterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and Licensing of Cetrorelix in Benign Prostatic Hyperplasia
8. Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreichs Ataxia Preclinical Development Program
9. Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development
10. BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines
11. Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014  A novel biomarker for ... physicians better identify early-stage disease, when treatment can ... to a new study in The Journal of ... DGX ) and other institutions found ... outperformed conventional antibody-serum testing, including rheumatoid factor (RF) ...
(Date:8/27/2014)... 27, 2014 Guggenheim Securities, the investment banking ... the hiring of veteran equity analyst Charles "Tony" Butler ... Butler will focus on the biotech/biopharma sector. ... of experience and a broad network of relationships in ... Director and Head of Equities at Guggenheim Securities. "His ...
(Date:8/27/2014)... 2014 Flagship Biosciences LLC, a leading ... the pharmaceutical and medical device industries, has announced a ... growing company has consolidated its histology and tissue analysis ... Westminster, CO, just north of Denver. The new ... 103rd Ave., Suite 100, Westminster, CO 80021 , Tissue ...
(Date:8/27/2014)... Aug. 27, 2014 Research and Markets ... Isotope Ratio Mass Spectrometer Industry Report 2014" report ... Isotope Ratio Mass Spectrometer Industry Report 2014 is a ... the global isotope ratio mass spectrometer industry. ... including definitions, classifications, applications and industry chain structure. The ...
Breaking Biology Technology:Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Flagship Biosciences Announces Relocation and Expansion 2Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014 2
... Calif., Oct. 26 iDiverse announced that it has ... number of lethal stresses normally encountered in the bioproduction ... the yeast to generate significantly more ethanol. ... proof-of-concept technology and are rapidly developing a 2nd generation ...
... a microwave oven, the fundamental nanotechnology process of ... use to make the ubiquitous semi-conductor chips. By ... Nanotechnology (NINT) and the University of Alberta have ... molecular self-assembly process used to assemble block copolymers, ...
... BSI Announces Global Launch of Clinical Strategy Review for CE Marking -- RESTON, Virginia, October 25, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
Cached Biology Technology:iDiverse Develops Stress Resistant Yeast for Producing Fuel Ethanol 2BSI Announces Global Launch of Clinical Strategy Review for CE Marking 2BSI Announces Global Launch of Clinical Strategy Review for CE Marking 3BSI Announces Global Launch of Clinical Strategy Review for CE Marking 4BSI Announces Global Launch of Clinical Strategy Review for CE Marking 5BSI Announces Global Launch of Clinical Strategy Review for CE Marking 6BSI Announces Global Launch of Clinical Strategy Review for CE Marking 7BSI Announces Global Launch of Clinical Strategy Review for CE Marking 8BSI Announces Global Launch of Clinical Strategy Review for CE Marking 9
(Date:8/27/2014)... getting effective doses of the HIV drug maraviroc, a ... studies, completed before the drug was licensed in 2007, ... is key to removing maraviroc from the body. The ... the protein including nearly half of African-Americans ... to those who lack the protein even when given ...
(Date:8/27/2014)... when it only requires nerve cells to rearrange existing ... to generate new patterns, a study of monkeys has ... through recordings of electrical activity of brain cell networks. ... of Health. , "We looked into the brain and ... outside the box," said Aaron Batista, Ph.D., an assistant ...
(Date:8/27/2014)... new skill is easier when it is related to ... pianist might learn a new melody more easily than ... engineers from the Center for the Neural Basis of ... and Carnegie Mellon Universityhave discovered a fundamental constraint in ... as the cover story in the Aug. 28, 2014, ...
Breaking Biology News(10 mins):Dosage of HIV drug may be ineffective for half of African-Americans 2Scientists plug into a learning brain 2Scientists plug into a learning brain 3Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3
... University School of Medicine (BUSM) report that physicians who use ... on patients with an abnormal Pap test could increase the ... achieve resolution in less time than using traditional methods. These ... . Screening for cervical cancer with a Pap ...
... the University of North Carolina at Chapel Hill School of ... the collateral circulation the "back-up" blood vessels that can ... heart attack or stroke. The new knowledge could help ... drugs or procedures that can cause new collaterals to ...
... oil and methane leaked into the Gulf of Mexico suggests ... the source of the pollution. The research investigates five scenarios ... an estimated rate of flow from the Deepwater Horizon spill, ... April to mid July of this year. A ...
Cached Biology News:Electronic tracking system can improve follow-up after an abnormal Pap test 2Genetics underlie formation of body's back-up bypass vessels 2Deep plumes of oil could cause dead zones in the Gulf 2
... (GR) Competitor Assay Kits are ideal for ... The PolarScreen GR Competitor Assay Kits contain ... and one of the following proprietary fluorescent ... GS Red (red assay kit), or GS ...
McCoy's 5A Medium. Without Tryptose or Phosphate Broth. Contains Sodium Bicarbonate....
... pathway is the major proteolytic system ... where it catalyzes the selective degradation ... rapid elimination of proteins with abnormal ... 1996). The critical protease in this ...
... to RFC1 Immunogen Recombinant protein corresponding ... C expressed in E. coli. Reactivity / ... Not yet tested in other species. This antibody ... Background Information Replication factor C is a ...
Biology Products: